Showing results (81-90 of 388) with videos related to
Sort By:
Pageof 39
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|December 16, 2021
Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumoursMohid S Khan, Elaine Stamp, Cormac Sammon, et al.Endocrinology|December 1, 1989
Enterohepatic circulation of triiodothyronine (T3) in rats: importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugatesM Rutgers, F A Heusdens, F Bonthuis, et al.Endocrinology|January 1, 1988
Effects of inhibition of type I iodothyronine deiodinase and phenol sulfotransferase on the biliary clearance of triiodothyronine in ratsW W de Herder, F Bonthuis, M Rutgers, et al.Clinical Endocrinology|September 14, 2012
The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET)George Kanakis, Kimberly Kamp, Konstantinos Tsiveriotis, et al.Neuroendocrinology|January 30, 2020
Importance of Complete Pathology Reporting for Neuroendocrine Carcinoma: WHO Guidelines Are a Good Start but Not EnoughWouter T Zandee, Jan Maarten van der Zwan, Wouter W de Herder, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 9, 2022
Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor PatientsNoémie S Minczeles, Wouter W de Herder, Richard A Feelders, et al.Trends in Endocrinology and Metabolism: TEM|March 1, 1990
The role of sulfation in thyroid hormone metabolismT J Visser, J C van Buuren, M Rutgers, et al.Clinical Nuclear Medicine|April 15, 2022
Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy Are More Prevalent in Women Than in MenNoémie S Minczeles, Wouter W de Herder, Mark W Konijnenberg, et al.European Journal of Endocrinology|August 1, 1995
Octreotide, but not bromocriptine, increases circulating insulin-like growth factor binding protein 1 levels in acromegalyW W de Herder, P Uitterlinden, A J van der Lely, et al.European Journal of Endocrinology|August 6, 2016
Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumoursWouter T Zandee, Kimberly Kamp, Roxanne C S van Adrichem, et al.Pageof 39